Risk Stratification Model for Surveillance Interval Extension After Hot Endoscopic Mucosal Resection of Large Non-Pedunculated Colon Polyps
Background: Current guidelines recommend uniform 6-month surveillance after endoscopic mucosal resection (EMR) of large non-pedunculated colon polyps (LNPCPs). We aimed to develop and validate a risk stratification model to identify lesions at lower recurrence risk. Methods: Retrospective multicenter study utilizing prospectively maintained databases across 12 centers (2017-2024) evaluated LNPCPs ≥20 mm removed by hot EMR. Twenty variables underwent multivariate Cox regression with stepwise selection to identify recurrence predictors. Validation was performed in a separate single-center cohort. Results: The derivation cohort included 463 patients with 491 LNPCPs. Multivariate analysis identified four independent predictors: evidence of prior resection (HR 1.97, 95% CI 1.04-3.72, p=0.03), absence of margin ablation (HR 1.96, 95% CI 1.22-3.23, p=0.01), villous histology (HR 1.77, 95% CI 1.09-2.86, p=0.02), and ileocecal valve (ICV) involvement (HR 2.66, 95% CI 1.29-5.45, p=0.01). Validation in a separate cohort (169 patients, 187 polyps) demonstrated effective risk stratification performance (p<0.01). In the validation cohort, low-risk polyps (no prior resection, margin ablation performed, no villous histology, no ICV involvement) had recurrence risks of 2.2%, 5.4%, and 9.7% at 6, 12, and 18 months respectively, compared to 10.6%, 23.1% and 28.1% in high-risk polyps. No patients in either cohort developed high-grade dysplasia or invasive adenocarcinoma during follow-up. Conclusions: A simple four-factor model incorporating prior resection, margin ablation, villous histology, and ICV involvement stratifies recurrence detection risk after hot EMR. Absence of high-risk features may help identify patients at lower recurrence risk and provides a framework for future prospective studies evaluating risk-adapted surveillance strategies.
Authors
- Douglas K. Pleskow (ORCID: https://orcid.org/0000-0003-0092-9496)
- Michael B. Wallace (ORCID: https://orcid.org/0000-0002-6446-5785)
- Saowanee Ngamruengphong (ORCID: https://orcid.org/0000-0003-0855-7500)
- Daniel von Renteln (ORCID: https://orcid.org/0000-0002-6125-0068)
- Thomas J. Wang (ORCID: https://orcid.org/0000-0003-4781-977X)
- Matthew Moyer (ORCID: https://orcid.org/0000-0001-7103-5890)
- Kanika Garg (ORCID: https://orcid.org/0009-0002-4613-6803)
- Aleksandar Gavrić (ORCID: https://orcid.org/0000-0002-4114-7397)
- John Guardiola (ORCID: https://orcid.org/0000-0002-4934-8628)
- Ajaypal Singh
- Neal Mehta (ORCID: https://orcid.org/0000-0001-8185-4478)
- Dennis Yang (ORCID: https://orcid.org/0000-0003-3038-4669)
- Christopher G. Chapman
- Stuart R. Gordon (ORCID: https://orcid.org/0000-0002-8824-0492)
- Joshua Melson
- Agnieszka Maniak
- John Levenick
- Benjamin Schwartz
- Heiko Pohl
- Douglas K. Rex
- Irving Waxman
- Mouen A Khashab
Institutions
- University of Southern California (US)
- Rush University Medical Center (US)
- Dartmouth–Hitchcock Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- Johns Hopkins University (US)
- AdventHealth Orlando (US)
- California Southern University (US)
- Ljubljana University Medical Centre (SI)
- Jacksonville College (US)
- White River Junction VA Medical Center (US)
- Banner - University Medical Center Tucson (US)
- Indiana University School of Medicine
- Indiana University (US)
- Université de Montréal (CA)
- Penn State Milton S. Hershey Medical Center (US)
Publication Details
- Journal
- Endoscopy
- Published
- 2026-09-15
- DOI
- https://doi.org/10.1055/a-2955-8379
- Primary Topic
- Gastric Cancer Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00